Financing, Equity Capital Markets

ALX Oncology

10/23
|
$63.2 Million
ALX
Piper Sandler served as bookrunner for ALX Oncology Holdings Inc. on a confidentially marketed follow-on offering
Sub-Type
Confidentially Marketed Follow-On Offering
Sub-Sector
Biopharma